We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year?
Read MoreHide Full Article
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Align Technology (ALGN - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.
Align Technology is one of 884 individual stocks in the Medical sector. Collectively, these companies sit at #5 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Align Technology is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for ALGN's full-year earnings has moved 3.9% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
According to our latest data, ALGN has moved about 4.4% on a year-to-date basis. Meanwhile, the Medical sector has returned an average of -5.9% on a year-to-date basis. This means that Align Technology is performing better than its sector in terms of year-to-date returns.
One other Medical stock that has outperformed the sector so far this year is Carlsmed, Inc. (CARL - Free Report) . The stock is up 2.4% year-to-date.
For Carlsmed, Inc., the consensus EPS estimate for the current year has increased 21.1% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, Align Technology belongs to the Medical - Dental Supplies industry, a group that includes 13 individual companies and currently sits at #65 in the Zacks Industry Rank. On average, stocks in this group have lost 8.4% this year, meaning that ALGN is performing better in terms of year-to-date returns.
In contrast, Carlsmed, Inc. falls under the Medical Info Systems industry. Currently, this industry has 41 stocks and is ranked #94. Since the beginning of the year, the industry has moved -24.1%.
Going forward, investors interested in Medical stocks should continue to pay close attention to Align Technology and Carlsmed, Inc. as they could maintain their solid performance.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Is Align Technology (ALGN) Stock Outpacing Its Medical Peers This Year?
The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Align Technology (ALGN - Free Report) is a stock that can certainly grab the attention of many investors, but do its recent returns compare favorably to the sector as a whole? Let's take a closer look at the stock's year-to-date performance to find out.
Align Technology is one of 884 individual stocks in the Medical sector. Collectively, these companies sit at #5 in the Zacks Sector Rank. The Zacks Sector Rank includes 16 different groups and is listed in order from best to worst in terms of the average Zacks Rank of the individual companies within each of these sectors.
The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. Align Technology is currently sporting a Zacks Rank of #2 (Buy).
Within the past quarter, the Zacks Consensus Estimate for ALGN's full-year earnings has moved 3.9% higher. This signals that analyst sentiment is improving and the stock's earnings outlook is more positive.
According to our latest data, ALGN has moved about 4.4% on a year-to-date basis. Meanwhile, the Medical sector has returned an average of -5.9% on a year-to-date basis. This means that Align Technology is performing better than its sector in terms of year-to-date returns.
One other Medical stock that has outperformed the sector so far this year is Carlsmed, Inc. (CARL - Free Report) . The stock is up 2.4% year-to-date.
For Carlsmed, Inc., the consensus EPS estimate for the current year has increased 21.1% over the past three months. The stock currently has a Zacks Rank #2 (Buy).
To break things down more, Align Technology belongs to the Medical - Dental Supplies industry, a group that includes 13 individual companies and currently sits at #65 in the Zacks Industry Rank. On average, stocks in this group have lost 8.4% this year, meaning that ALGN is performing better in terms of year-to-date returns.
In contrast, Carlsmed, Inc. falls under the Medical Info Systems industry. Currently, this industry has 41 stocks and is ranked #94. Since the beginning of the year, the industry has moved -24.1%.
Going forward, investors interested in Medical stocks should continue to pay close attention to Align Technology and Carlsmed, Inc. as they could maintain their solid performance.